{"@id":"https://bioecon.ru/technology/monoclonal-antibodies/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/monoclonal-antibodies/","json":"https://en.bioecon.ru/api/v1/technology/monoclonal-antibodies/index.json"},"id":"monoclonal-antibodies","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/loopworm/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/hlb-genex/"]},"maturity":7,"name":"Monoclonal Antibodies","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"High-throughput B-cell cloning"},{"n":2,"title":"Transient and stable expression"},{"n":3,"title":"Downstream Protein A purification"},{"n":4,"title":"Biophysical formulation"}],"summary":"Scalable mammalian cell culture platforms for high-titer recombinant monoclonal antibody generation, supporting catalog research reagents, diagnostic probes, and therapeutic-grade molecules.","url":"/technology/monoclonal-antibodies/","verified":"2026-11-22"}